Abstract
Background Current spirometric-based criteria for diagnosis of bronchiolitis obliterans syndrome (BOS) may miss early peripheral airway disease associate with disease onset. Multiple breath washout (MBW) and oscillometry offer improved sensitivity, but longitudinal changes occurring in allogeneic haematopoietic stem cell transplantation (HSCT) are unknown.
Objective In this longitudinal study of HSCT survivors, we investigated changes in nitrogen-based MBW, oscillometry and conventional lung function, from baseline (pre-transplant), over 36-months, and associations with BOS Stage 0p, a spirometry-defined risk classification for potential later BOS development, and chronic graft-vs-host disease (cGVHD).
Study Design Longitudinal observational study of allogeneic HSCT recipients from a single adult centre. All participants underwent spirometry, plethysmography, gas transfer capacity (DLCO), oscillometry and MBW at each study visit. Tests were performed pre-HSCT and 3 monthly thereafter over 36 months.
Results 64 of 69 recipients recruited were included in the final analysis. Across the entire cohort, deterioration in acinar ventilation inhomogeneity (Sacin) occurred as early as 90 days post-HSCT (0.224 z score change/month, p<0.001), prior to any significant change in spirometry or oscillometry. Progressive deteriorations in Sacin were associated with cGVHD status and grade but not BOS-0p status.
Conclusions Early progressive peripheral airway dysfunction occurred following HSCT and was best detected by Sacin from MBW. Distal acinar ventilation inhomogeneity (Sacin) deteriorated at an earlier stage than spirometry. Longitudinal deteriorations in Sacin were related to cGVHD, and independent of early changes in spirometry parameters. These findings suggest an important role of the lung in cGVHD and provide important evidence to support future studies examining the prognostic utility of MBW in long-term monitoring of HSCT patients to provide an early effective signal of BOS.
Highlights The evolution of peripheral airway function abnormality assessed using Multiple Breath Washout (MBW) and oscillometry following allogeneic HSCT is unknown.
Progressive abnormality is established early following HSCT and occurred in those who developed chronic graft versus host disease (cGHVD) in other organ systems.
This highlights the risk of peripheral airway dysfunction in those affected by cGVHD.
MBW to monitor post-HSCT subjects provides additional insight to that provided by BOS-0p criteria which did not show the same relationship to cGHVD.
These findings identify a potential window for earlier targeted treatment to improve long term outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Christopher Htun received financial support from the Australian and New Zealand Society of Respiratory Science (ANZSRS Research Grant 2013).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consent occurred at entry to the study which was approved by Northern Sydney Local Health District Human Research Ethics Committee (Protocol Number: LNR/13/HAWKE/11).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
